Whole-blood proliferation assay for autoimmune thyroid disease: Comparisonto density-gradient separated-peripheral blood lymphocytes

Citation
Wg. Butscher et al., Whole-blood proliferation assay for autoimmune thyroid disease: Comparisonto density-gradient separated-peripheral blood lymphocytes, THYROID, 11(6), 2001, pp. 531-537
Citations number
9
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
THYROID
ISSN journal
10507256 → ACNP
Volume
11
Issue
6
Year of publication
2001
Pages
531 - 537
Database
ISI
SICI code
1050-7256(200106)11:6<531:WPAFAT>2.0.ZU;2-4
Abstract
Autoimmune thyroid diseases feature prominent cellular infiltration of the thyroid gland as well as autoantibody production to thyroid antigens. The m ost common assay to evaluate cell-mediated immunity is based on incorporati on of tritiated thymidine into proliferating T cells after stimulation by t he test antigens. In the past, cell proliferation assays of thyroglobulin ( Tg) using peripheral blood mononuclear cells (PBMC) of individuals with aut oimmune thyroid diseases required large quantities of blood and specialized separation techniques, and have not yielded high counts or high stimulatio n indices. We therefore developed a proliferation assay using less than 5 m L of whole blood and compared proliferation of cells in whole blood to that using PBMCs separated by density gradient centrifugation. We also determin ed if responses could be enhanced by addition of interleukin-2 (IL-2) to th e cultures. We found that an IL-2-stimulated proliferation assay to Tg usin g diluted whole blood is superior to the separated cell assay in detecting Tg-specific T-cell proliferation in autoimmune thyroid disease patients. Fu rther refinement of this technique and larger trials may confirm its value for clinical investigation and special diagnostic applications.